OSTEOMARK NTX POINT OF CARE PRESCRIPTION HOME USE

Column Chromatography & Color Development, Hydroxyproline

OSTEX INTL., INC.

The following data is part of a premarket notification filed by Ostex Intl., Inc. with the FDA for Osteomark Ntx Point Of Care Prescription Home Use.

Pre-market Notification Details

Device IDK011052
510k NumberK011052
Device Name:OSTEOMARK NTX POINT OF CARE PRESCRIPTION HOME USE
ClassificationColumn Chromatography & Color Development, Hydroxyproline
Applicant OSTEX INTL., INC. 2203 AIRPORT WAY SOUTH, SUITE 400 Seattle,  WA  98134
ContactNancy Js Mallinak
CorrespondentNancy Js Mallinak
OSTEX INTL., INC. 2203 AIRPORT WAY SOUTH, SUITE 400 Seattle,  WA  98134
Product CodeJMM  
CFR Regulation Number862.1400 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2001-04-06
Decision Date2001-07-30

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.